Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Baduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial) [NA]
An update on the BE-PREMIER trial evaluating Baduanjin exercise to prevent post-myocardial infarction left ventricular remodeling; the curre…
-
CLINICAL_TRIALS research · 2016-08-05Clinical Trial Update: Exenatide for Myocardial Protection During Reperfusion Study [Phase 2]
Phase 2 study update evaluating Exenatide for myocardial protection during reperfusion in myocardial infarction; the trial status is current…
-
CLINICAL_TRIALS research · 2016-08-02Clinical Trial Update: The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients [Phase 4]
This Phase 4 clinical trial update investigates Tongguan Capsule and its effect on microRNA profiles in patients with coronary artery diseas…
-
FDA approval · 2016-07-29FDA Approved: QBRELIS — Original Application (Azurity Pharmaceuticals, Inc.)
The FDA approved QBRELIS (lisinopril) through an original NDA from Azurity Pharmaceuticals. It is indicated for hypertension, heart failure,…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [Phase 3]
Phase 3 ALLHAT trial update reporting completed results evaluating antihypertensive therapies (chlorthalidone, lisinopril, amlodipine, and d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEAD
This document summarizes results from an ancillary Look AHEAD trial examining MRI-derived changes in organ and tissue mass with weight loss.…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEAD
An update on an NHLBI ancillary study to Look AHEAD investigating heavy metals, obesity, and cardiovascular risk; the trial has completed.
-
CLINICAL_TRIALS research · 2016-07-29Clinical Trial Update: Revascularization Strategies for STEMI; The CMR Endpoint Study [NA]
This clinical trial update discusses a study comparing revascularization strategies for ST-segment elevation myocardial infarction, evaluate…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Worcester Heart Attack Community Surveillance Study
The Worcester Heart Attack Community Surveillance Study, sponsored by the NHLBI, has completed. It targets cardiovascular diseases including…
-
CLINICAL_TRIALS research · 2016-07-27Clinical Trial Update: Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
An update on a clinical trial studying plasma GLP-1 in patients with acute myocardial infarction undergoing percutaneous coronary interventi…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Ad-HGF Treatment for Myocardial Infarction [Phase 1, Phase 2]
This document provides an update on a Phase 1/Phase 2 trial evaluating Ad-HGF therapy for myocardial infarction.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Short-term Air Pollution Exposure and In-hospital Outcomes in Patients With Acute Myocardial Infraction
This clinical trial update examines how short-term air pollution exposure affects in-hospital outcomes for patients with acute myocardial in…
-
CLINICAL_TRIALS research · 2016-07-25Clinical Trial Update: Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years
A retrospective, multi-year clinical study update evaluating acute chest pain in extremely critical patients, encompassing acute myocardial …
-
FDA approval · 2016-07-22FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP. The action concerns a supplem…
-
CLINICAL_TRIALS safety_alert · 2016-07-19Clinical Trial Update: A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
A completed postmarketing study comparing cardiovascular risks in women using ORTHO EVRA vs traditional oral contraceptives, focusing on ven…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Postmarketing study evaluating the relationship between ORTHO EVRA and risks of venous thromboembolism, stroke, and myocardial infarction ha…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Validation of Simple Acute Coronary Syndrome (SACS) Score
This clinical trial update reports on the validation of the Simple Acute Coronary Syndrome (SACS) Score for assessing patients with chest pa…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Non-invasive Diagnosis of Coronary Artery Stenoses by Doppler Echocardiography [NA]
A clinical trial evaluating non-invasive diagnosis of coronary artery stenosis using Doppler echocardiography has completed, studying patien…
-
CLINICAL_TRIALS research · 2016-07-15Clinical Trial Update: Chronic Remote Ischemic Conditioning to Modify Post-MI Remodeling [NA]
Clinical trial update on using chronic remote ischemic conditioning to influence remodeling after myocardial infarction.
-
FDA approval · 2016-07-13FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet) under ANDA 076102 to authorize the generic produ…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Beta-Blocker Heart Attack Trial (BHAT) [Phase 3]
This update reports the completion of the Phase 3 Beta-Blocker Heart Attack Trial (BHAT), a study of beta-blocker therapy in patients after …
-
FDA approval · 2016-07-12FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA has approved a supplemental application for Effient (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc. This action…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Multicenter Investigation of Limitation of Infarct Size (MILIS) [Phase 3]
Phase 3 multicenter trial MILIS evaluating strategies to limit infarct size in myocardial infarction has completed enrollment and is reporte…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Thrombus Aspiration in Myocardial Infarction [NA]
A clinical trial update indicates that a thrombus aspiration study in acute myocardial infarction has completed.
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)
An update on the COREA-AMI II trial aiming to identify high-risk patients following acute myocardial infarction and PCI.